1. Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients. Issue 965 (3rd March 2006) Authors: Rosner, G; Lurie, Y; Blendis, L; Halpern, Z; Oren, R Journal: Postgraduate medical journal Issue: Volume 82:Issue 965(2006) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice. (January 1997) Authors: Bruck, R; Shirin, H; Hershkoviz, R; Lider, O; Kenet, G; Aeed, H; Matas, Z; Zaidel, L; Halpern, Z Journal: Gut Issue: Volume 40(1997)Supplement 1 Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial. Issue 9 (September 1985) Authors: Bar-Meir, S; Halpern, Z; Gutman, M; Shpirer, Z; Baratz, M; Bass, D Journal: Gut Issue: Volume 26:Issue 9(1985) Page Start: 975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of lipid infusion on bile composition and lithogenicity in patients without cholesterol gall stones. Issue 10 (October 1992) Authors: Rubin, M; Halpern, Z; Charach, G; Dvir, A; Antebi, E; Gilat, T; Lichtenberg, D Journal: Gut Issue: Volume 33:Issue 10(1992) Page Start: 1400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles. Issue 1 (January 1993) Authors: Halpern, Z; Moshkowitz, M; Laufer, H; Peled, Y; Gilat, T Journal: Gut Issue: Volume 34:Issue 1(1993) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fatty acid bile acid conjugates (FABACs)—New molecules for the prevention of cholesterol crystallisation in bile. Issue 1 (1st January 2001) Authors: Gilat, T; Somjen, G J; Mazur, Y; Leikin-Frenkel, A; Rosenberg, R; Halpern, Z; Konikoff, FM Journal: Gut Issue: Volume 48:Issue 1(2001) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ileitis after colectomy for ulcerative colitis or carcinoma. Issue 3 (March 1994) Authors: Hallak, A; Baratz, M; Santo, M; Halpern, Z; Rabau, M; Werbin, N; Gilat, T Journal: Gut Issue: Volume 35:Issue 3(1994)Supplement Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1: New non‐invasive model, based on serum bile acid levels and patient's parameters for liver fibrosis assessment in patients with chronic hepatitis C. (23rd September 2013) Authors: Halfon, P; Goldiner, I; Zelber‐Sagi, S; Halpern, Z; Oren, R; Shlomai, A; Bruck, R Journal: Journal of viral hepatitis Issue: Volume 20(2013)Supplement 3 Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗